Company profile

Sight Diagnostics Ltd.

Sight Diagnostics Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on November 1, 2019 and the most recent on November 1, 2019 (Sight OLO). Its most common review panel is Hematology (1 device).

1AI devices

2019First decision

2019Latest decision

1Specialties

Timeline

November 1, 2019 · 510(k) K190898Sight OLO · Hematology · GKZ